MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

Search

IDEXX Laboratories Inc

Chiusa

SettoreSettore sanitario

533.03 -1.46

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

526.8

Massimo

535.98

Metriche Chiave

By Trading Economics

Entrata

27M

243M

Vendite

44M

998M

P/E

Media del settore

50.515

39.564

EPS

2.96

Margine di Profitto

24.306

Dipendenti

11,000

EBITDA

54M

352M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+2.39% upside

Dividendi

By Dow Jones

Utili prossimi

4 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

6.3B

44B

Apertura precedente

534.49

Chiusura precedente

533.03

Notizie sul Sentiment di mercato

By Acuity

10%

90%

6 / 376 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

IDEXX Laboratories Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

11 lug 2025, 22:19 UTC

Acquisizioni, Fusioni, Takeovers

FCC Approves U.S. Cellular Sale to T-Mobile

11 lug 2025, 17:28 UTC

I principali Market Mover

SharpLink Gaming Gains on Ethereum Purchase

11 lug 2025, 16:57 UTC

Utili

BASF Cuts Outlook on Global Economy Uncertainty

11 lug 2025, 21:45 UTC

Discorsi di Mercato

Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk

11 lug 2025, 19:46 UTC

Acquisizioni, Fusioni, Takeovers

Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com

11 lug 2025, 19:45 UTC

Discorsi di Mercato

Crude Futures Post Back-to-Back Weekly Gains -- Market Talk

11 lug 2025, 19:05 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk

11 lug 2025, 18:18 UTC

Discorsi di Mercato

Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk

11 lug 2025, 17:35 UTC

Discorsi di Mercato

Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk

11 lug 2025, 17:26 UTC

Discorsi di Mercato

U.S. Oil Rig Count Down by 1 to 424 -- Market Talk

11 lug 2025, 16:53 UTC

Discorsi di Mercato

Crude Futures Add to Early Gains -- Market Talk

11 lug 2025, 16:42 UTC

Utili

BASF Cuts Outlook on Global Economic Uncertainty

11 lug 2025, 16:08 UTC

Discorsi di Mercato

Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk

11 lug 2025, 16:05 UTC

Utili

BASF Will Publish Half-Year Results on July 30

11 lug 2025, 16:04 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

11 lug 2025, 16:04 UTC

Discorsi di Mercato

Senior Housing Shortage Gives REITs Pricing Power -- Market Talk

11 lug 2025, 16:03 UTC

Utili

BASF: Guidance Cut Is Due to Ongoing Macroeconomic, Geopolitical Uncertainties

11 lug 2025, 16:02 UTC

Utili

BASF Continues to Expect Free Cash Flow Between EUR400M and EUR800M in 2025

11 lug 2025, 16:01 UTC

Utili

BASF Had Seen Ebitda Before Special Items Between EUR8B and EUR8.4B in 2025

11 lug 2025, 16:00 UTC

Utili

BASF Now Sees Ebitda Before Special Items Between EUR7.3B and EUR7.7B in 2025

11 lug 2025, 15:59 UTC

Utili

BASF Cuts 2025 Earnings View

11 lug 2025, 15:58 UTC

Utili

Nvidia's CEO Has Sold a Million Shares. He Has Millions More to Sell. -- Barrons.com

11 lug 2025, 15:57 UTC

Utili

BASF 2Q EBIT Before Special Items EUR810M

11 lug 2025, 15:54 UTC

Utili

BASF: Analysts Had Expected 2Q Sales of EUR15.80B

11 lug 2025, 15:54 UTC

Utili

BASF 2Q Sales Fell 2.1% on Year

11 lug 2025, 15:53 UTC

Utili

BASF 2Q Sales EUR15.77B

11 lug 2025, 15:52 UTC

Utili

BASF: This Was in Line With Consensus Estimates

11 lug 2025, 15:52 UTC

Utili

BASF 2Q Ebitda Before Special Items EUR1.77B

11 lug 2025, 15:49 UTC

Utili

BASF Reports Preliminary 2Q Figures, Adjusts 2025 Outlook

11 lug 2025, 15:41 UTC

Discorsi di Mercato

Oil, Gas Prices Not Seen Supporting Drilling Boom -- Market Talk

Confronto tra pari

Modifica del prezzo

IDEXX Laboratories Inc Previsione

Obiettivo di Prezzo

By TipRanks

2.39% in crescita

Previsioni per 12 mesi

Media 554 USD  2.39%

Alto 625 USD

Basso 475 USD

Basato su 9 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per IDEXX Laboratories Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

9 ratings

6

Acquista

3

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

440.98 / N/ASupporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Strong Bullish Evidence

A lungo termine

Weak Bullish Evidence

Sentiment

By Acuity

6 / 376 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo IDEXX Laboratories Inc

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.